Literature DB >> 8549869

Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm.

F M Matschinsky1.   

Abstract

Special features of glucose metabolism in pancreatic beta-cells are central to an understanding of the physiological role of these cells in glucose homeostasis. Several of these characteristics are emphasized: a high-capacity system for glucose transport; glucose phosphorylation by the high-Km glucokinase (GK), which is rate-limiting for glucose metabolism and determines physiologically the glucose dependency curves of many processes in beta-cell intermediary and energy metabolism and of insulin release and is therefore viewed as glucose sensor; remarkably low activity of lactate dehydrogenase and the presence of effective hydrogen shuttles to allow virtually quantitative oxidation of glycolytic NADH; the near absence of glycogen and fatty acid synthesis and of gluconeogenesis, such that intermediary metabolism is primarily catabolic; a crucial role of mitochondrial processes, including the citric acid cycle, electron transport, and oxidative phosphorylation with FoF1 ATPase governing the glucose-dependent increase of the ATP mass-action ratio; a Ca(2+)-independent glucose-induced respiratory burst and increased ATP production in beta-cells as striking manifestations of crucial mitochondrial reactions; control of the membrane potential by the mass-action ratio of ATP and voltage-dependent Ca2+ influx as signal for insulin release; accumulation of malonyl-CoA, acyl-CoA, and diacylglycerol as essential or auxiliary metabolic coupling factors; and amplification of the adenine nucleotide, lipid-related, and Ca2+ signals to recruit many auxiliary processes to maximize insulin biosynthesis and release. The biochemical design also suggests certain candidate diabetes genes related to fuel metabolism: low-activity and low-stability GK mutants that explain in part the maturity-onset diabetes of the young (MODY) phenotype in humans and mitochondrial DNA mutations of FoF1 ATPase components thought to cause late-onset diabetes in BHEcdb rats. These two examples are chosen to illustrate that metabolic reactions with high control strength participating in beta-cell energy metabolism and generating coupling factors and intracellular signals are steps with great susceptibility to genetic, environmental, and pharmacological influences. Glucose metabolism of beta-cells also controls, in addition to insulin secretion and insulin biosynthesis, an adaptive response to excessive fuel loads and may increase the beta-cell mass by hypertrophy, hyperplasia, and neogenesis. It is probable that this adaptive response is compromised in diabetes because of the GK or ATPase mutants that are highlighted here. A comprehensive knowledge of beta-cell intermediary and energy metabolism is therefore the foundation for understanding the role of these cells in fuel homeostasis and in the pathogenesis of the most prevalent metabolic disease, diabetes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8549869     DOI: 10.2337/diab.45.2.223

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  151 in total

1.  A kinase in the life of the beta cell.

Authors:  D Accili
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

2.  Activities of enzymes related to the malate-aspartate shuttle in the blood cells of thoroughbred horses undergoing training exercise.

Authors:  T Arai; M Takahashi; K Araki; T Washizu
Journal:  Vet Res Commun       Date:  2001-10       Impact factor: 2.459

3.  Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor.

Authors:  Shouhong Xuan; Tadahiro Kitamura; Jun Nakae; Katerina Politi; Yoshiaki Kido; Peter E Fisher; Manrico Morroni; Saverio Cinti; Morris F White; Pedro L Herrera; Domenico Accili; Argiris Efstratiadis
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

4.  The Gordon Wilson Lecture. Lessons about the control of glucose homeostasis and the pathogenesis of diabetes from knockout mice.

Authors:  C Ronald Kahn
Journal:  Trans Am Clin Climatol Assoc       Date:  2003

5.  Go2 G protein mediates galanin inhibitory effects on insulin release from pancreatic β cells.

Authors:  Guanghua Tang; Ying Wang; Sangeun Park; Neil S Bajpayee; Diana Vi; Yoshiko Nagaoka; Lutz Birnbaumer; Meisheng Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

6.  Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics.

Authors:  Nicolai M Doliba; Wei Qin; Habiba Najafi; Chengyang Liu; Carol W Buettger; Johanna Sotiris; Heather W Collins; Changhong Li; Charles A Stanley; David F Wilson; Joseph Grimsby; Ramakanth Sarabu; Ali Naji; Franz M Matschinsky
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-09-27       Impact factor: 4.310

7.  The glucose sensor protein glucokinase is expressed in glucagon-producing alpha-cells.

Authors:  H Heimberg; A De Vos; K Moens; E Quartier; L Bouwens; D Pipeleers; E Van Schaftingen; O Madsen; F Schuit
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

8.  Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the β cell.

Authors:  Regina Kuliawat; Laura Klein; Zhenwei Gong; Marianna Nicoletta-Gentile; Anjana Nemkal; Lingguang Cui; Claire Bastie; Kai Su; Derek Huffman; Manju Surana; Nir Barzilai; Norman Fleischer; Radhika Muzumdar
Journal:  FASEB J       Date:  2013-08-30       Impact factor: 5.191

Review 9.  Homeostasis, inflammation, and disease susceptibility.

Authors:  Maya E Kotas; Ruslan Medzhitov
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

10.  Dominant-negative suppression of HNF-1alpha function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic beta-cell line.

Authors:  H Wang; P Maechler; K A Hagenfeldt; C B Wollheim
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.